Phosphoprotein Phosphatases
"Phosphoprotein Phosphatases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of enzymes removing the SERINE- or THREONINE-bound phosphate groups from a wide range of phosphoproteins, including a number of enzymes which have been phosphorylated under the action of a kinase. (Enzyme Nomenclature, 1992)
| Descriptor ID |
D010749
|
| MeSH Number(s) |
D08.811.277.352.650.625
|
| Concept/Terms |
Phosphoprotein Phosphatases- Phosphoprotein Phosphatases
- Phosphatases, Phosphoprotein
- Serine-Threonine Phosphatase
- Phosphatase, Serine-Threonine
- Serine Threonine Phosphatase
- Protein Phosphatases
- Phosphatases, Protein
- Protein-Serine-Threonine Phosphatase
- Phosphatase, Protein-Serine-Threonine
- Protein Serine Threonine Phosphatase
- Phosphoprotein Phosphatase
- Phosphatase, Phosphoprotein
- Phosphoprotein Phosphohydrolase
- Phosphohydrolase, Phosphoprotein
Protein-Threonine Phosphatase- Protein-Threonine Phosphatase
- Phosphatase, Protein-Threonine
- Protein Threonine Phosphatase
- Threonine Phosphatase
- Phosphatase, Threonine
|
Below are MeSH descriptors whose meaning is more general than "Phosphoprotein Phosphatases".
Below are MeSH descriptors whose meaning is more specific than "Phosphoprotein Phosphatases".
This graph shows the total number of publications written about "Phosphoprotein Phosphatases" by people in this website by year, and whether "Phosphoprotein Phosphatases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 2 | 2 |
| 2000 | 2 | 2 | 4 |
| 2001 | 2 | 1 | 3 |
| 2002 | 4 | 1 | 5 |
| 2003 | 6 | 2 | 8 |
| 2004 | 2 | 2 | 4 |
| 2005 | 4 | 0 | 4 |
| 2006 | 2 | 4 | 6 |
| 2007 | 4 | 2 | 6 |
| 2009 | 2 | 1 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phosphoprotein Phosphatases" by people in Profiles.
-
Eto M, Katsuki S, Ohashi M, Miyagawa Y, Tanaka Y, Takeya K, Kitazawa T. Possible roles of N- and C-terminal unstructured tails of CPI-17 in regulating Ca2+ sensitization force of smooth muscle. J Smooth Muscle Res. 2022; 58(0):22-33.
-
Filter JJ, Williams BC, Eto M, Shalloway D, Goldberg ML. Unfair competition governs the interaction of pCPI-17 with myosin phosphatase (PP1-MYPT1). Elife. 2017 04 07; 6.
-
Eto M, Kitazawa T. Diversity and plasticity in signaling pathways that regulate smooth muscle responsiveness: Paradigms and paradoxes for the myosin phosphatase, the master regulator of smooth muscle contraction. J Smooth Muscle Res. 2017; 53(0):1-19.
-
Stickles XB, Marchion DC, Bicaku E, Al Sawah E, Abbasi F, Xiong Y, Bou Zgheib N, Boac BM, Orr BC, Judson PL, Berry A, Hakam A, Wenham RM, Apte SM, Berglund AE, Lancaster JM. BAD-mediated apoptotic pathway is associated with human cancer development. Int J Mol Med. 2015 Apr; 35(4):1081-7.
-
Eto M, Kirkbride JA, Chugh R, Karikari NK, Kim JI. Nuclear localization of CPI-17, a protein phosphatase-1 inhibitor protein, affects histone H3 phosphorylation and corresponds to proliferation of cancer and smooth muscle cells. Biochem Biophys Res Commun. 2013 Apr 26; 434(1):137-42.
-
Eto M, Brautigan DL. Endogenous inhibitor proteins that connect Ser/Thr kinases and phosphatases in cell signaling. IUBMB Life. 2012 Sep; 64(9):732-9.
-
Bouazza B, Krytska K, Debba-Pavard M, Amrani Y, Honkanen RE, Tran J, Tliba O. Cytokines alter glucocorticoid receptor phosphorylation in airway cells: role of phosphatases. Am J Respir Cell Mol Biol. 2012 Oct; 47(4):464-73.
-
Eto M. Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors. J Biol Chem. 2009 Dec 18; 284(51):35273-7.
-
Kitazawa T, Semba S, Huh YH, Kitazawa K, Eto M. Nitric oxide-induced biphasic mechanism of vascular relaxation via dephosphorylation of CPI-17 and MYPT1. J Physiol. 2009 Jul 15; 587(Pt 14):3587-603.
-
Adler JT, Cook M, Luo Y, Pitt SC, Ju J, Li W, Shen B, Kunnimalaiyaan M, Chen H. Tautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3beta. Mol Cancer Ther. 2009 Apr; 8(4):914-20.